Skip to main content
. 2015 Feb 3;9(2):e0003449. doi: 10.1371/journal.pntd.0003449

Figure 2. Human antibody response to Phlebotomus papatasi salivary protein PpSP32.

Figure 2

(a) Comparison of anti-PpSP32 antibody levels in healthy individuals from the ZCL regions of Al Ahsa and Al Madinah (b) Anti-PpSP32 antibody levels in ZCL patients with active and cured infections from Al Ahsa. (c) Anti-PpSP32 antibody levels in ZCL patients with active and cured infections from the region of Al Madinah. Control: healthy individuals; CL: active infection; CR: cured infection; OD: optical density. * P≤ .05; ** P ≤ .01; *** P ≤ .001.